Literature DB >> 27448992

Optimising the quality and outcomes of treatments for diabetic foot infections.

O Robineau1, S Nguyen1, E Senneville1.   

Abstract

INTRODUCTION: Infection is the commonest foot complication that arises in people with diabetes and may lead to amputation and even death. The emergence of multidrug resistant bacteria, especially in Gram negative rods, may have a negative impact on the chances of cure in these patients. AREAS COVERED: We searched the Medline and Pubmed databases for studies using the keywords 'diabetic foot infection' and 'diabetic foot osteomyelits' from 1980 to 2016. Expert commentary: Much has been done in the field of diabetic foot infection regarding pathophysiology, diagnosis and treatment. The construction of multidisciplinary teams is probably the most efficient way to improve the patients' outcome. The rational use of antibiotics and surgical skills are essential in these potentially severe infections. Each case of diabetic infection deserves to be discussed in the light of the current guidelines and the local resources. Because of the overal poor outcome of these infections, prevention remains a priority.

Entities:  

Keywords:  Diabetic foot infections; antibiotics; outcome; prevention; surgery; treatment

Mesh:

Substances:

Year:  2016        PMID: 27448992     DOI: 10.1080/14787210.2016.1214072

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  2 in total

1.  The effectiveness of systemic antibiotics for osteomyelitis of the foot in adults with diabetes mellitus: a systematic review protocol.

Authors:  Akram Uddin; David Russell; Fran Game; Derek Santos; Heidi J Siddle
Journal:  J Foot Ankle Res       Date:  2022-06-17       Impact factor: 3.050

2.  Novel Alkylimidazolium Ionic Liquids as an Antibacterial Alternative to Pathogens of the Skin and Soft Tissue Infections.

Authors:  Oscar Forero Doria; Ricardo Castro; Margarita Gutierrez; Diego Gonzalez Valenzuela; Leonardo Santos; David Ramirez; Luis Guzman
Journal:  Molecules       Date:  2018-09-14       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.